Background. The prognosis of pancreatic adenocarcinoma (PAAD) is extremely poor and
has not been improved. Thus, an effective method to assess the prognosis of patients must …

Background Pancreatic adenocarcinoma (PAAD) is a highly lethal and aggressive tumor
with poor prognoses. The predictive capability of immune-related genes (IRGs) in PAAD has …

Background Pancreatic adenocarcinoma (PAAD) is a nonimmunogenic tumor, and very little
is known about the relationship between the host immune response and patient survival. We …

Pancreatic adenocarcinoma (PAAD) has high mortality and a very poor prognosis. Both
surgery and chemotherapy have a suboptimal therapeutic effect, and this caused a need to …

Pancreatic cancer remains to have a high mortality, which is partly due to the lack of effective
treatment strategies. In this study, genes with potential associations with …

Abstract Background Immune-related genes (IRGs) are associated with the prognosis of
different cancers and are helpful for the diagnosis and management of systematic treatment …

Objective Our goal is to construct an immune-related gene prognostic risk index (IRGPRI) for
pancreatic adenocarcinoma (PAAD), and to clarify the immune and molecular features in …

Purpose: To identify differentially expressed immune-related genes (DEIRGs) and construct
a model with survival-related DEIRGs for evaluating the prognosis of patients with …

Background Pancreatic cancer is one of the most common malignant tumors of the digestive
tract, and it has a poor prognosis. Traditional methods are not effective to accurately assess …

Background The immune response in the tumor microenvironment (TME) plays a crucial role
in cancer progression and recurrence. We aimed to develop an immune-related gene (IRG) …